Study of Netarsudil Ophthalmic Solution in Japanese/Japanese-American Subjects With Open-angle Glaucoma or Ocular Hypertension

NCT03310580 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Open Angle Glaucoma or Ocular Hypertension

Interventions

DRUG: AR-13324 Ophthalmic Solution 0.02%
DRUG: AR-13324 Ophthalmic Solution 0.04%
DRUG: AR-13324 Ophthalmic Solution Placebo

Sponsor

Aerie Pharmaceuticals